30 results
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
Treatment • Invasive pulmonary ... eye Infectious Diseases ... Aspergillosis #Treatment #management ... #pharmacology # ... IDSA
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Opportunistic Disease ... Mycobacterium tuberculosis ... complex (MAC) disease ... #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Opportunistic Disease ... Mycobacterium tuberculosis ... complex (MAC) disease ... #management #pharmacology
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... Multidrug-Resistant Tuberculosis ... #MDRTB #management ... antimicrobials #pharmacology ... #dosing #idsa #
Doses of Antituberculosis Drugs for Adults and Children - IDSA
First-line drugs:
 • Isoniazid
 • Rifampin
 •
and Children - IDSA ... Moxifloxacin #Tuberculosis ... #Medications #management ... #pharmacology #
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Microbiologically Confirmed Pulmonary ... Tuberculosis - ... IDSA Guidelines ... #Tuberculosis ... #medications #pharmacology
Causes of Pleural Effusion - Differential Diagnosis Algorithm
Transudate - Hydrostatic
 • Congestive heart failure
 • Constrictive
Pneumonia • Tuberculous ... Malignancy • Pulmonary ... Collagen vascular disease ... Gastrointestinal disease ... • Uremia • Meigs
Pott's Disease in Tuberculosis - Diagnosis and Management Summary
Epidemiology:
 - Typically from TB endemic areas
 -
Pott's Disease in ... Tuberculosis - ... symptoms of active pulmonary ... for concomitant pulmonary ... CMC_IM #Potts #Disease
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Chronic kidney disease ... Disease Progression ... • HIV: 2/3 pulmonary ... Disease Progression ... TB #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Chronic kidney disease ... Disease Progression ... • HIV: 2/3 pulmonary ... Disease Progression ... TB #Diagnosis #Management